Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -0.94% | -3.67% | -85.42% |
05-16 | AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 | CI |
05-16 | AEON Biopharma, Inc. Announces Executive Changes | CI |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
EBIT
- Stock Market
- Equities
- AEON Stock
- Revisions AEON Biopharma, Inc.